產(chǎn)品中心
當(dāng)前位置:首頁
產(chǎn)品中心
抗體/抗原
抗體試劑盒
S0M1033PI3K-AKT Pathway MiniAb Set(Human Only)
產(chǎn)品型號(hào):S0M1033
更新時(shí)間:2025-08-10
廠商性質(zhì):生產(chǎn)廠家
訪問量:83
15855403091
產(chǎn)品分類
The PI3K-AKT signaling pathway?is a crucial cellular signaling pathway that plays a significant role in various cellular processes, including growth, proliferation, survival, and metabolism。
?
Components:
PI3K (Phosphoinositide 3-kinase): A family of enzymes that phosphorylate the inositol ring of phosphatidylinositol (PI) to produce phosphatidylinositol 3-phosphate (PIP3).
AKT (also known as Protein Kinase B): A serine/threonine kinase that is activated by PIP3 and plays a central role in mediating the effects of growth factors and insulin.
PTEN (Phosphatase and Tensin Homolog): A tumor suppressor that dephosphorylates PIP3 back to PIP2, thus negatively regulating the pathway.
?
Activation:
?
The pathway is typically activated by various growth factors, hormones, and cytokines that bind to receptor tyrosine kinases (RTKs) or G-protein-coupled receptors (GPCRs).
Upon activation, these receptors recruit and activate PI3K, leading to the conversion of PIP2 to PIP3 in the plasma membrane.
?
Downstream Effects:
?
AKT Activation: PIP3 recruits AKT to the membrane, where it is phosphorylated and activated by 3-phosphoinositide-dependent protein kinase 1 (PDK1) and mTORC2.
Cell Survival and Growth: Activated AKT promotes cell survival by inhibiting pro-apoptotic factors (e.g., BAD, caspase-9) and enhancing the activity of anti-apoptotic factors (e.g., Bcl-2).
Metabolism: AKT regulates glucose metabolism by promoting glucose uptake and glycolysis through the activation of glucose transporters and enzymes involved in metabolic pathways.
Cell Cycle Progression: AKT influences cell cycle progression by regulating cyclins and cyclin-dependent kinases (CDKs).
?
Clinical Relevance:
?
Dysregulation of the PI3K-AKT pathway is implicated in various diseases, particularly cancer, where mutations in components like PI3K or loss of PTEN function can lead to uncontrolled cell growth and survival.
The pathway is a target for therapeutic interventions, with several inhibitors of PI3K and AKT currently being investigated or used in clinical settings.
關(guān)于我們
公司簡介 企業(yè)文化 榮譽(yù)資質(zhì)產(chǎn)品分類
抗體/抗原 蛋白新聞文章
新聞中心 技術(shù)文章聯(lián)系我們
聯(lián)系方式 在線留言 地圖導(dǎo)航15855403091
(全國服務(wù)熱線)浙江省杭州市上城區(qū)同協(xié)路1279號(hào)西子智慧產(chǎn)業(yè)園7號(hào)樓4層
關(guān)注公眾號(hào)
Copyright © 2025杭州斯達(dá)特生物科技有限公司 All Rights Reserved 工信部備案號(hào):
技術(shù)支持:化工儀器網(wǎng) 管理登錄 sitemap.xml